Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 275

1.

Pharmacological treatments for generalised anxiety disorder - Authors' reply.

Freemantle N, Slee A, Nazareth I.

Lancet. 2019 Oct 5;394(10205):1230. doi: 10.1016/S0140-6736(19)31415-1. No abstract available.

PMID:
31591982
2.

Effectiveness of cognitive-behavioural therapy for depression in advanced cancer: CanTalk randomised controlled trial.

Serfaty M, King M, Nazareth I, Moorey S, Aspden T, Mannix K, Davis S, Wood J, Jones L.

Br J Psychiatry. 2019 Sep 30:1-9. doi: 10.1192/bjp.2019.207. [Epub ahead of print]

PMID:
31566164
3.

Response to: 'Chronic hydroxychloroquine exposure and the risk of Alzheimer's disease' by Lai et al.

Fardet L, Petersen I, Nazareth I.

Ann Rheum Dis. 2019 Aug 31. pii: annrheumdis-2019-216182. doi: 10.1136/annrheumdis-2019-216182. [Epub ahead of print] No abstract available.

PMID:
31473595
4.

Comparative effectiveness of sitagliptin vs sulphonylureas in older people.

Sharma M, Nazareth I, Petersen I.

Age Ageing. 2019 Jun 28. pii: afz078. doi: 10.1093/ageing/afz078. [Epub ahead of print]

PMID:
31250890
5.

A randomised controlled trial assessing the use of citalopram, sertraline, fluoxetine and mirtazapine in preventing relapse in primary care patients who are taking long-term maintenance antidepressants (ANTLER: ANTidepressants to prevent reLapse in dEpRession): study protocol for a randomised controlled trial.

Duffy L, Bacon F, Clarke CS, Donkor Y, Freemantle N, Gilbody S, Hunter R, Kendrick T, Kessler D, King M, Lanham P, Lewis G, Mangin D, Marston L, Moore M, Nazareth I, Wiles N, Lewis G.

Trials. 2019 Jun 3;20(1):319. doi: 10.1186/s13063-019-3390-8.

6.

Family physicians' views on participating in prevention of major depression. The predictD-EVAL qualitative study.

Moreno-Peral P, Conejo-Cerón S, Fernández A, Martín-Pérez C, Fernández-Alonso C, Rodríguez-Bayón A, Ballesta-Rodríguez MI, Aiarzagüena JM, Montón-Franco C, King M, Nazareth I, Bellón JÁ.

PLoS One. 2019 May 30;14(5):e0217621. doi: 10.1371/journal.pone.0217621. eCollection 2019.

7.
8.

Manualised cognitive-behavioural therapy in treating depression in advanced cancer: the CanTalk RCT.

Serfaty M, King M, Nazareth I, Moorey S, Aspden T, Tookman A, Mannix K, Gola A, Davis S, Wood J, Jones L.

Health Technol Assess. 2019 May;23(19):1-106. doi: 10.3310/hta23190.

9.

Primary care management of cardiovascular risk for people with severe mental illnesses: the Primrose research programme including cluster RCT.

Osborn D, Burton A, Walters K, Atkins L, Barnes T, Blackburn R, Craig T, Gilbert H, Gray B, Hardoon S, Heinkel S, Holt R, Hunter R, Johnston C, King M, Leibowitz J, Marston L, Michie S, Morris R, Morris S, Nazareth I, Omar R, Petersen I, Peveler R, Pinfold V, Stevenson F, Zomer E.

Southampton (UK): NIHR Journals Library; 2019 Apr.

10.

Health indicator recording in UK primary care electronic health records: key implications for handling missing data.

Petersen I, Welch CA, Nazareth I, Walters K, Marston L, Morris RW, Carpenter JR, Morris TP, Pham TM.

Clin Epidemiol. 2019 Feb 11;11:157-167. doi: 10.2147/CLEP.S191437. eCollection 2019.

11.

Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis.

Slee A, Nazareth I, Bondaronek P, Liu Y, Cheng Z, Freemantle N.

Lancet. 2019 Feb 23;393(10173):768-777. doi: 10.1016/S0140-6736(18)31793-8. Epub 2019 Jan 31. Erratum in: Lancet. 2019 Apr 27;393(10182):1698.

PMID:
30712879
12.

Persistent unexplained physical symptoms: a prospective longitudinal cohort study in UK primary care.

Lamahewa K, Buszewicz M, Walters K, Marston L, Nazareth I.

Br J Gen Pract. 2019 Apr;69(681):e246-e253. doi: 10.3399/bjgp19X701249. Epub 2019 Jan 28.

PMID:
30692088
13.

Observational studies of treatment effectiveness: worthwhile or worthless?

Sharma M, Nazareth I, Petersen I.

Clin Epidemiol. 2018 Dec 18;11:35-42. doi: 10.2147/CLEP.S178723. eCollection 2019.

14.

Response to: 'Chronic hydroxychloroquine/chloroquine exposure for connective tissue diseases and risk of Alzheimer's disease' by Lee.

Fardet L, Petersen I, Nazareth I.

Ann Rheum Dis. 2018 Oct 18. pii: annrheumdis-2018-214515. doi: 10.1136/annrheumdis-2018-214515. [Epub ahead of print] No abstract available.

PMID:
30337423
15.

Chronic hydroxychloroquine/chloroquine exposure for connective tissue diseases and risk of Alzheimer's disease: a population-based cohort study.

Fardet L, Nazareth I, Petersen I.

Ann Rheum Dis. 2019 Feb;78(2):279-282. doi: 10.1136/annrheumdis-2018-214016. Epub 2018 Sep 5. No abstract available.

PMID:
30185414
16.
17.

Weight change over two years in people prescribed olanzapine, quetiapine and risperidone in UK primary care: Cohort study in THIN, a UK primary care database.

Osborn DP, Petersen I, Beckley N, Walters K, Nazareth I, Hayes J.

J Psychopharmacol. 2018 Oct;32(10):1098-1103. doi: 10.1177/0269881118780011. Epub 2018 Jun 25.

PMID:
29938561
18.

Landmark Models for Optimizing the Use of Repeated Measurements of Risk Factors in Electronic Health Records to Predict Future Disease Risk.

Paige E, Barrett J, Stevens D, Keogh RH, Sweeting MJ, Nazareth I, Petersen I, Wood AM.

Am J Epidemiol. 2018 Jul 1;187(7):1530-1538. doi: 10.1093/aje/kwy018.

19.

Factors influencing recording of drug misuse in primary care: a qualitative study of GPs in England.

Davies-Kershaw H, Petersen I, Nazareth I, Stevenson F.

Br J Gen Pract. 2018 Apr;68(669):e234-e244. doi: 10.3399/bjgp18X695309. Epub 2018 Feb 26.

20.

A personalized intervention to prevent depression in primary care: cost-effectiveness study nested into a clustered randomized trial.

Fernández A, Mendive JM, Conejo-Cerón S, Moreno-Peral P, King M, Nazareth I, Martín-Pérez C, Fernández-Alonso C, Rodríguez-Bayón A, Aiarzaguena JM, Montón-Franco C, Serrano-Blanco A, Ibañez-Casas I, Rodríguez-Sánchez E, Salvador-Carulla L, Garay PB, Ballesta-Rodríguez MI, LaFuente P, Del Mar Muñoz-García M, Mínguez-Gonzalo P, Araujo L, Palao D, Gómez MC, Zubiaga F, Navas-Campaña D, Aranda-Regules JM, Rodriguez-Morejón A, de Dios Luna J, Bellón JÁ.

BMC Med. 2018 Feb 23;16(1):28. doi: 10.1186/s12916-018-1005-y.

21.

Cost-effectiveness of a community-delivered multicomponent intervention compared with enhanced standard care of obese adolescents: cost-utility analysis alongside a randomised controlled trial (the HELP trial).

Panca M, Christie D, Cole TJ, Costa S, Gregson J, Holt R, Hudson LD, Kessel AS, Kinra S, Mathiot A, Nazareth I, Wataranan J, Wong ICK, Viner RM, Morris S.

BMJ Open. 2018 Feb 15;8(2):e018640. doi: 10.1136/bmjopen-2017-018640.

22.

Clinical and cost-effectiveness of an intervention for reducing cholesterol and cardiovascular risk for people with severe mental illness in English primary care: a cluster randomised controlled trial.

Osborn D, Burton A, Hunter R, Marston L, Atkins L, Barnes T, Blackburn R, Craig T, Gilbert H, Heinkel S, Holt R, King M, Michie S, Morris R, Morris S, Nazareth I, Omar R, Petersen I, Peveler R, Pinfold V, Walters K.

Lancet Psychiatry. 2018 Feb;5(2):145-154. doi: 10.1016/S2215-0366(18)30007-5. Epub 2018 Jan 22. Erratum in: Lancet Psychiatry. 2019 Jan;6(1):e2.

23.
24.

Cost-effectiveness of personal tailored risk information and taster sessions to increase the uptake of the NHS stop smoking services: the Start2quit randomized controlled trial.

Wu Q, Gilbert H, Nazareth I, Sutton S, Morris R, Petersen I, Galton S, Parrott S.

Addiction. 2018 Apr;113(4):708-718. doi: 10.1111/add.14086. Epub 2017 Dec 11.

25.

Effectiveness of sitagliptin compared to sulfonylureas for type 2 diabetes mellitus inadequately controlled on metformin: a systematic review and meta-analysis.

Sharma M, Beckley N, Nazareth I, Petersen I.

BMJ Open. 2017 Oct 30;7(10):e017260. doi: 10.1136/bmjopen-2017-017260. Review.

26.

Living and dying with advanced dementia: A prospective cohort study of symptoms, service use and care at the end of life.

Sampson EL, Candy B, Davis S, Gola AB, Harrington J, King M, Kupeli N, Leavey G, Moore K, Nazareth I, Omar RZ, Vickerstaff V, Jones L.

Palliat Med. 2018 Mar;32(3):668-681. doi: 10.1177/0269216317726443. Epub 2017 Sep 18.

27.

Effectiveness and cost-effectiveness of a cardiovascular risk prediction algorithm for people with severe mental illness (PRIMROSE).

Zomer E, Osborn D, Nazareth I, Blackburn R, Burton A, Hardoon S, Holt RIG, King M, Marston L, Morris S, Omar R, Petersen I, Walters K, Hunter RM.

BMJ Open. 2017 Sep 5;7(9):e018181. doi: 10.1136/bmjopen-2017-018181.

28.

The role of self-regulatory skills and automaticity on the effectiveness of a brief weight loss habit-based intervention: secondary analysis of the 10 top tips randomised trial.

Kliemann N, Vickerstaff V, Croker H, Johnson F, Nazareth I, Beeken RJ.

Int J Behav Nutr Phys Act. 2017 Sep 5;14(1):119. doi: 10.1186/s12966-017-0578-8.

30.

Implementing the compassion intervention, a model for integrated care for people with advanced dementia towards the end of life in nursing homes: a naturalistic feasibility study.

Moore KJ, Candy B, Davis S, Gola A, Harrington J, Kupeli N, Vickerstaff V, King M, Leavey G, Nazareth I, Omar RZ, Jones L, Sampson EL.

BMJ Open. 2017 Jul 10;7(6):e015515. doi: 10.1136/bmjopen-2016-015515.

31.

A community-based motivational personalised lifestyle intervention to reduce BMI in obese adolescents: results from the Healthy Eating and Lifestyle Programme (HELP) randomised controlled trial.

Christie D, Hudson LD, Kinra S, Wong ICK, Nazareth I, Cole TJ, Sovio U, Gregson J, Kessel AS, Mathiot A, Morris S, Panca M, Costa S, Holt R, Viner RM.

Arch Dis Child. 2017 Aug;102(8):695-701. doi: 10.1136/archdischild-2016-311586. Epub 2017 Jul 7.

32.

Experiences of end of life amongst family carers of people with advanced dementia: longitudinal cohort study with mixed methods.

Moore KJ, Davis S, Gola A, Harrington J, Kupeli N, Vickerstaff V, King M, Leavey G, Nazareth I, Jones L, Sampson EL.

BMC Geriatr. 2017 Jul 3;17(1):135. doi: 10.1186/s12877-017-0523-3.

33.

Statin prescribing for prevention of cardiovascular disease amongst people with severe mental illness: Cohort study in UK primary care.

Blackburn R, Osborn D, Walters K, Nazareth I, Petersen I.

Schizophr Res. 2018 Feb;192:219-225. doi: 10.1016/j.schres.2017.05.028. Epub 2017 Jun 7.

34.

Association Between Long-term Quinine Exposure and All-Cause Mortality.

Fardet L, Nazareth I, Petersen I.

JAMA. 2017 May 9;317(18):1907-1909. doi: 10.1001/jama.2017.2332. No abstract available.

35.

Health care resource use by patients before and after a diagnosis of chronic fatigue syndrome (CFS/ME): a clinical practice research datalink study.

Collin SM, Bakken IJ, Nazareth I, Crawley E, White PD.

BMC Fam Pract. 2017 May 5;18(1):60. doi: 10.1186/s12875-017-0635-z.

36.

Ketogenic diet in the treatment of epilepsy in children under the age of 2 years: study protocol for a randomised controlled trial.

Titre-Johnson S, Schoeler N, Eltze C, Williams R, Vezyroglou K, McCullagh H, Freemantle N, Heales S, Kneen R, Marston L, Martland T, Nazareth I, Neal E, Lux A, Parker A, Agrawal S, Fallon P, Cross JH.

Trials. 2017 Apr 26;18(1):195. doi: 10.1186/s13063-017-1918-3.

37.

Predicting the onset of hazardous alcohol drinking in primary care: development and validation of a simple risk algorithm.

Bellón JÁ, de Dios Luna J, King M, Nazareth I, Motrico E, GildeGómez-Barragán MJ, Torres-González F, Montón-Franco C, Sánchez-Celaya M, Díaz-Barreiros MÁ, Vicens C, Moreno-Peral P.

Br J Gen Pract. 2017 Apr;67(657):e280-e292. doi: 10.3399/bjgp17X690245.

38.

Trends in the incidence of chronic fatigue syndrome and fibromyalgia in the UK, 2001-2013: a Clinical Practice Research Datalink study.

Collin SM, Bakken IJ, Nazareth I, Crawley E, White PD.

J R Soc Med. 2017 Jun;110(6):231-244. doi: 10.1177/0141076817702530. Epub 2017 Mar 30.

39.

Statin prescribing for people with severe mental illnesses: a staggered cohort study of 'real-world' impacts.

Blackburn R, Osborn D, Walters K, Falcaro M, Nazareth I, Petersen I.

BMJ Open. 2017 Mar 7;7(3):e013154. doi: 10.1136/bmjopen-2016-013154.

40.

Antiepileptic drugs prescribed in pregnancy and prevalence of major congenital malformations: comparative prevalence studies.

Petersen I, Collings SL, McCrea RL, Nazareth I, Osborn DP, Cowen PJ, Sammon CJ.

Clin Epidemiol. 2017 Feb 16;9:95-103. doi: 10.2147/CLEP.S118336. eCollection 2017.

41.

Impact of Financial Incentives on Alcohol Consumption Recording in Primary Health Care Among Adults with Schizophrenia and Other Psychoses: A Cross-Sectional and Retrospective Cohort Study.

Khadjesari Z, Hardoon SL, Petersen I, Hamilton FL, Nazareth I.

Alcohol Alcohol. 2017 Mar 9;52(2):197-205. doi: 10.1093/alcalc/agw076. No abstract available.

42.

Effectiveness of personalised risk information and taster sessions to increase the uptake of smoking cessation services (Start2quit): a randomised controlled trial.

Gilbert H, Sutton S, Morris R, Petersen I, Galton S, Wu Q, Parrott S, Nazareth I.

Lancet. 2017 Feb 25;389(10071):823-833. doi: 10.1016/S0140-6736(16)32379-0. Epub 2017 Jan 25.

43.

Start2quit: a randomised clinical controlled trial to evaluate the effectiveness and cost-effectiveness of using personal tailored risk information and taster sessions to increase the uptake of the NHS Stop Smoking Services.

Gilbert H, Sutton S, Morris R, Petersen I, Wu Q, Parrott S, Galton S, Kale D, Magee MS, Gardner L, Nazareth I.

Health Technol Assess. 2017 Jan;21(3):1-206. doi: 10.3310/hta21030.

44.

Relative risks of cardiovascular disease in people prescribed olanzapine, risperidone and quetiapine.

Osborn D, Marston L, Nazareth I, King MB, Petersen I, Walters K.

Schizophr Res. 2017 May;183:116-123. doi: 10.1016/j.schres.2016.11.009. Epub 2016 Nov 22.

PMID:
27884434
45.

A brief intervention for weight control based on habit-formation theory delivered through primary care: results from a randomised controlled trial.

Beeken RJ, Leurent B, Vickerstaff V, Wilson R, Croker H, Morris S, Omar RZ, Nazareth I, Wardle J.

Int J Obes (Lond). 2017 Feb;41(2):246-254. doi: 10.1038/ijo.2016.206. Epub 2016 Nov 21.

46.

Initiation and duration of selective serotonin reuptake inhibitor prescribing over time: UK cohort study.

McCrea RL, Sammon CJ, Nazareth I, Petersen I.

Br J Psychiatry. 2016 Nov;209(5):421-426. Epub 2016 Aug 18.

PMID:
27539294
47.

An algorithm for identification and classification of individuals with type 1 and type 2 diabetes mellitus in a large primary care database.

Sharma M, Petersen I, Nazareth I, Coton SJ.

Clin Epidemiol. 2016 Oct 12;8:373-380. eCollection 2016.

48.

Risks associated with antipsychotic treatment in pregnancy: Comparative cohort studies based on electronic health records.

Petersen I, Sammon CJ, McCrea RL, Osborn DPJ, Evans SJ, Cowen PJ, Nazareth I.

Schizophr Res. 2016 Oct;176(2-3):349-356. doi: 10.1016/j.schres.2016.07.023. Epub 2016 Jul 30.

49.

An ethnographic study of strategies to support discussions with family members on end-of-life care for people with advanced dementia in nursing homes.

Saini G, Sampson EL, Davis S, Kupeli N, Harrington J, Leavey G, Nazareth I, Jones L, Moore KJ.

BMC Palliat Care. 2016 Jul 7;15:55. doi: 10.1186/s12904-016-0127-2.

50.

Supplemental Content

Loading ...
Support Center